Last update 20 Mar 2025

Brilanestrant

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Brilanestrant (USAN/INN)
+ [4]
Target
Action
antagonists
Mechanism
ERα antagonists(Estrogen receptor alpha antagonists)
Originator Organization
Inactive Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H20ClFN2O2
InChIKeyBURHGPHDEVGCEZ-KJGLQBJMSA-N
CAS Registry1365888-06-7

External Link

KEGGWikiATCDrug Bank
D11264Brilanestrant-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced breast cancerPreclinical
Australia
04 Dec 2015
Advanced breast cancerPreclinical
Spain
04 Dec 2015
Advanced breast cancerPreclinical
United Kingdom
04 Dec 2015
Advanced breast cancerPreclinical
United States
04 Dec 2015
Advanced breast cancerPreclinical
South Korea
04 Dec 2015
Advanced breast cancerPreclinical
Germany
04 Dec 2015
Estrogen receptor positive breast cancerPreclinical
Netherlands
29 Dec 2014
Estrogen receptor positive breast cancerPreclinical
Spain
29 Dec 2014
Estrogen receptor positive breast cancerPreclinical
United States
29 Dec 2014
Estrogen receptor positive breast cancerPreclinical
South Korea
29 Dec 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
71
(GDC-0810)
evgjkvpvvu(qtsnkbfbmo) = dvfyklhnpa arbybiidko (sjoiypsqdi, lzqqshzbwn - hogkwtozku)
-
23 Apr 2021
(Fulvestrant)
evgjkvpvvu(qtsnkbfbmo) = xjisbygffk arbybiidko (sjoiypsqdi, ejdyrwkyek - nwgbosdwwa)
Phase 1
41
(ktdqdfftay) = 600 mg QD given with food qutikvahat (uqpyorpwys )
Positive
01 Aug 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free